Yastin Suneja Analyst PerformanceSenior Managing Director, Biotechnology Research Analyst at GuggenheimYastin Suneja is a stock analyst at Guggenheim focused in the healthcare sector, covering 46 publicly traded companies. Over the past year, Yastin Suneja has issued 93 stock ratings, including strong buy, buy, and hold recommendations. While full access to Yastin Suneja's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yastin Suneja's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings150 Last 7 YearsBuy Recommendations90.67% 136 Buy RatingsCompanies Covered46 Unique Companies Ratings Distribution150RatingsDistribution of strong buy, buy, hold, and sell ratings by Yastin Suneja.RatingPercentageCount Strong Buy0.7%1 ratings Buy90.0%135 ratings Hold9.3%14 ratings Sell0.0%0 ratingsOut of 150 total stock ratings issued by Yastin Suneja at Guggenheim, the majority (90.0%) have been Buy recommendations, followed by 9.3% Hold and 0.7% Strong Buy.Best & Worst CallsBest Call000000.0%ABVXJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%QTTBJun 2024Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ46 companiesYastin Suneja, an analyst at Guggenheim, currently covers 46 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare44 companies95.7%Miscellaneous2 companies4.3%Yastin Suneja of Guggenheim specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY36 companies78.3%PHARMACEUTICALS8 companies17.4%Miscellaneous2 companies4.3% About Yastin SunejaMr. Suneja is a Senior Managing Director and Equity Research Analyst covering the Biotechnology sector, with over 16 years of experience in equity research. Since joining Guggenheim in 2018, he has provided in-depth analysis and investment insights on biotechnology companies, with a particular focus on those in the immunology, neurology, and inflammatory (INI) space. Previously, he was a Managing Director at SunTrust Robinson Humphrey and a Vice President at Cowen & Company, both specializing in biotechnology equity research. He began his career in Corporate Banking at Bank of America. Mr. Suneja holds an M.B.A. from Syracuse University and a B.Com from PGDAV College, University of Delhi.Follow on LinkedIn Yastin Suneja's Ratings History at Guggenheim Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAVTXAvalo Therapeutics10/23/2026Reiterated Rating$7.45Neutral$0.0000.00% ROIABVXAbivax10/20/2026Reiterated Rating$87.49$175.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals10/19/2026Downgrade$0.42Neutral$0.0000.00% ROIZBIOZenas BioPharma9/30/2026Reiterated Rating$26.76$55.00Buy$0.0000.00% ROIKRSACyclerion Therapeutics9/28/2026Initiated Coverage$31.00$70.00Buy$0.0000.00% ROITRAXFirst Tracks Biotherapeutics9/16/2026Initiated Coverage$38.47$100.00Buy$0.0000.00% ROITRAXFirst Tracks Biotherapeutics9/16/2026Initiated Coverage$38.47$100.00Buy$0.0000.00% ROITRAXFirst Tracks Biotherapeutics9/16/2026Initiated Coverage$39.00$100.00Buy$0.0000.00% ROIROIVRoivant Sciences9/9/2026Boost Price Target$41.48$46.00Buy$0.0000.00% ROIALMSAlumis9/3/2026Downgrade$10.35Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. LTGOLatigo Biotherapeutics9/1/2026Initiated Coverage$22.02$50.00Buy$0.0000.00% ROILTGOLatigo Biotherapeutics9/1/2026Initiated Coverage$22.26$50.00Buy$0.0000.00% ROIZBIOZenas BioPharma8/14/2026Reiterated Rating$29.04$55.00Buy$0.0000.00% ROIZURAZura Bio8/12/2026Boost Price Target$5.56$20.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics8/11/2026Boost Price Target$220.89$275.00Buy$0.0000.00% ROIORKAOruka Therapeutics8/11/2026Reiterated Rating$103.25$200.00Buy$0.0000.00% ROISIONSionna Therapeutics8/10/2026Downgrade$4.46Neutral$0.0000.00% ROIAVTXAvalo Therapeutics8/7/2026Set Price Target$18.70$48.00Buy$0.0000.00% ROISIONSionna Therapeutics8/7/2026Boost Price Target$49.61$60.00Buy$0.0000.00% ROIROIVRoivant Sciences8/7/2026Boost Price Target$36.09$42.00Buy$0.0000.00% ROIACETAdicet Bio8/6/2026Reiterated Rating$9.11$90.00Buy$0.0000.00% ROISYRESpyre Therapeutics8/5/2026Boost Price Target$106.85$130.00Buy$0.0000.00% ROISTOKStoke Therapeutics8/4/2026Reiterated Rating$30.07$60.00Buy$0.0000.00% ROIARGXargenex8/4/2026Initiated Coverage$844.27$1,185.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals7/31/2026Lower Price Target$8.92$22.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences7/31/2026Boost Price Target$165.52$222.00Buy$0.0000.00% ROIARGXargenex7/24/2026Boost Price Target$924.08$1,185.00Buy$0.0000.00% ROIBIIBBiogen7/21/2026Boost Price Target$202.12$280.00Buy$0.0000.00% ROICLDXCelldex Therapeutics7/20/2026Boost Price Target$35.35$100.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals6/24/2026Reiterated Rating$14.55$68.00Buy$0.0000.00% ROICLYMClimb Bio6/8/2026Initiated Coverage$10.55$35.00Buy$0.0000.00% ROICLYMClimb Bio6/8/2026Initiated Coverage$10.77$35.00Buy$0.0000.00% ROIOCSOculis6/1/2026Lower Price Target$22.70$45.00Buy$0.0000.00% ROIROIVRoivant Sciences5/26/2026Boost Price Target$29.96$36.00Buy$0.0000.00% ROIIMVTImmunovant5/26/2026Boost Price Target$34.15$62.00Buy$0.0000.00% ROIOCSOculis5/20/2026Initiated Coverage$27.91$75.00Buy$0.0000.00% ROIOCSOculis5/20/2026Upgrade$31.00Strong-Buy$0.0000.00% ROIALMSAlumis5/15/2026Boost Price Target$24.63$34.00Buy$0.0000.00% ROIARGXargenex5/8/2026Boost Price Target$787.31$1,135.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences5/6/2026Reiterated Rating$144.75$175.00Buy$0.0000.00% ROIThe $100 Stock Behind Elon's Next Move (Ad)A small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for more than a decade. A federal filing may outline Musk's next major move: an AI network of up to a million satellites powered by the sun. James Altucher says this supplier holds the piece Musk doesn't own.Watch James Altucher's free Masterclass on this Musk-linked supplier stockAXSMAxsome Therapeutics5/4/2026Boost Price Target$227.50$260.00Buy$0.0000.00% ROIDBVTDBV Technologies5/4/2026Reiterated Rating$19.10$51.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/1/2026Boost Price Target$704.44$995.00Buy$0.0000.00% ROIBIIBBiogen4/30/2026Boost Price Target$194.38$260.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/27/2026Set Price Target$80.91$200.00Buy$0.0000.00% ROIIFRXInflaRx4/21/2026Reiterated Rating$1.63$14.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/13/2026Reiterated Rating$61.89$125.00Buy$0.0000.00% ROINMRANeumora Therapeutics3/31/2026Reiterated Rating$1.93$14.00Buy$0.0000.00% ROIDBVTDBV Technologies3/27/2026Reiterated Rating$20.21$51.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics3/25/2026Boost Price Target$158.75$245.00Buy$0.0000.00% ROIIMUXImmunic3/24/2026Initiated Coverage$11.70$70.00Buy$0.0000.00% ROICABACabaletta Bio3/24/2026Boost Price Target$2.70$16.00Buy$0.0000.00% ROIIFRXInflaRx3/20/2026Lower Price Target$0.91$14.00Buy$0.0000.00% ROIZBIOZenas BioPharma3/16/2026Boost Price Target$23.23$55.00Buy$0.0000.00% ROIORKAOruka Therapeutics3/13/2026Reiterated Rating$31.99$60.00Buy$0.0000.00% ROIACETAdicet Bio3/13/2026Lower Price Target$7.04$100.00Buy$0.0000.00% ROIXENEXenon Pharmaceuticals3/9/2026Reiterated Rating$62.63$90.00Buy$0.0000.00% ROISIONSionna Therapeutics3/2/2026Boost Price Target$33.68$50.00Buy$0.0000.00% ROIARGXargenex2/27/2026Lower Price Target$771.53$1,120.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals2/27/2026Boost Price Target$12.94$25.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics2/24/2026Boost Price Target$174.76$220.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines2/10/2026Reiterated Rating$319.54$800.00Buy$0.0000.00% ROIBIIBBiogen2/9/2026Boost Price Target$201.18$246.00Buy$0.0000.00% ROIIMVTImmunovant2/9/2026Boost Price Target$27.05$44.00Buy$0.0000.00% ROIROIVRoivant Sciences2/9/2026Boost Price Target$25.86$30.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals2/9/2026Boost Price Target$784.43$975.00Buy$0.0000.00% ROISTOKStoke Therapeutics2/5/2026Initiated Coverage$32.00$60.00Buy$0.0000.00% ROISTOKStoke Therapeutics2/5/2026Initiated Coverage$32.40$60.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics2/2/2026Initiated Coverage$15.11$50.00Buy$0.0000.00% ROIRAPTRapt Therapeutics1/20/2026Downgrade$57.52Neutral$0.0000.00% ROIALMSAlumis1/7/2026Boost Price Target$16.23$32.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics1/2/2026Reiterated Rating$177.09$205.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/29/2025Reiterated Rating$301.40Buy$0.0000.00% ROISABSSAB Biotherapeutics12/19/2025Initiated Coverage$3.95$15.00Buy$0.0000.00% ROISABSSAB Biotherapeutics12/19/2025Initiated Coverage$3.84$15.00Buy$0.0000.00% ROIROIVRoivant Sciences12/18/2025Reiterated Rating$22.70$28.00Buy$0.0000.00% ROIIMVTImmunovant12/18/2025Reiterated Rating$26.98$41.00Buy$0.0000.00% ROIANABAnaptysBio12/18/2025Reiterated Rating$45.60Buy$0.0000.00% ROIABVXAbivax12/18/2025Reiterated Rating$110.82$175.00Buy$0.0000.00% ROIDBVTDBV Technologies12/17/2025Reiterated Rating$17.98$51.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/9/2025Reiterated Rating$270.98$760.00Buy$0.0000.00% ROIDBVTDBV Technologies12/3/2025Initiated Coverage$12.90$35.00Buy$0.0000.00% ROIDBVTDBV Technologies12/3/2025Initiated Coverage$12.99$35.00Buy$0.0000.00% ROIROIVRoivant Sciences11/14/2025Reiterated Rating$20.56$25.00Buy$0.0000.00% ROIIFRXInflaRx11/10/2025Boost Price Target$1.23$22.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines11/6/2025Reiterated Rating$172.35$540.00Buy$0.0000.00% ROIANABAnaptysBio11/5/2025Boost Price Target$36.13$100.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics11/4/2025Boost Price Target$134.39$205.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals10/30/2025Reiterated Rating$13.31$20.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/29/2025Boost Price Target$654.48$865.00Buy$0.0000.00% ROICigar Lake Flooded Again Uranium Supply Shock Repeats (Ad)In 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This past May, flooding hit the same complex again, and in July Cigar Lake went down a second time, disrupting the world's largest high-grade uranium mine. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.See the three companies positioned for uranium's next supply shockORKAOruka Therapeutics10/27/2025Initiated Coverage$27.25$60.00Buy$0.0000.00% ROIRAPTRapt Therapeutics10/27/2025Initiated Coverage$29.53$70.00Buy$0.0000.00% ROINMRANeumora Therapeutics10/27/2025Upgrade$2.63$14.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines10/16/2025Set Price Target$189.69$350.00Buy$000.0000.00% ROIABVXAbivax10/10/2025Boost Price Target$90.61$150.00Buy$00.0000.00% ROIACETAdicet Bio10/8/2025Boost Price Target$13.65$128.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics9/30/2025Lower Price Target$6.24$20.00Buy$00.0000.00% ROIACETAdicet Bio9/19/2025Reiterated Rating$12.97$112.00Buy$0.0000.00% ROIARGXargenex9/18/2025Reiterated Rating$734.77$1,070.00Buy$000.0000.00% ROIROIVRoivant Sciences9/18/2025Boost Price Target$15.42$21.00Buy$00.0000.00% ROITRMLTourmaline Bio9/10/2025Reiterated Rating$47.64$48.00Neutral$0.0000.00% ROITRMLTourmaline Bio9/9/2025Downgrade$47.64Hold$0.0000.00% ROIDNTHDianthus Therapeutics9/9/2025Boost Price Target$31.80$100.00Buy$000.0000.00% ROIFBRXForte Biosciences8/18/2025Initiated Coverage$11.57$75.00Buy$00.0000.00% ROIFBRXForte Biosciences8/18/2025Initiated Coverage$11.49$75.00Buy$00.0000.00% ROITRMLTourmaline Bio8/14/2025Reiterated Rating$21.88$55.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals8/1/2025Boost Price Target$545.46$815.00Buy$000.0000.00% ROINBIXNeurocrine Biosciences8/1/2025Boost Price Target$126.03$175.00Buy$000.0000.00% ROIARGXargenex8/1/2025Boost Price Target$667.75$1,070.00Buy$000.0000.00% ROIABVXAbivax7/23/2025Boost Price Target$10.00$101.00Buy$000.0000.00% ROILRMRLarimar Therapeutics6/24/2025Reiterated Rating$2.42$26.00Buy$0.0000.00% ROIALMSAlumis6/10/2025Upgrade$3.43$18.00Buy$00.0000.00% ROIANABAnaptysBio5/28/2025Reiterated Rating$21.95$90.00Buy$00.0000.00% ROICABACabaletta Bio5/15/2025Boost Price Target$1.70$25.00Buy$0.0000.00% ROIARGXargenex5/9/2025Lower Price Target$547.89$1,065.00Buy$000.0000.00% ROIANABAnaptysBio5/6/2025Boost Price Target$20.97$54.00Buy$00.0000.00% ROINBIXNeurocrine Biosciences5/6/2025Boost Price Target$125.03$165.00Buy$000.0000.00% ROIPHATPhathom Pharmaceuticals5/2/2025Lower Price Target$2.76$12.00Buy$00.0000.00% ROIREGNRegeneron Pharmaceuticals5/1/2025Lower Price Target$589.21$810.00Buy$000.0000.00% ROIPHATPhathom Pharmaceuticals4/2/2025Reiterated Rating$5.98Buy$00.0000.00% ROICABACabaletta Bio4/1/2025Reiterated Rating$1.32$23.00Buy$0.0000.00% ROIZURAZura Bio3/26/2025Reiterated Rating$1.37$15.00Buy$0.0000.00% ROIIFRXInflaRx3/26/2025Boost Price Target$1.33$10.00Buy$0.0000.00% ROILRMRLarimar Therapeutics3/25/2025Reiterated Rating$2.29$26.00Buy$0.0000.00% ROIIMVTImmunovant3/20/2025Reiterated Rating$18.84Buy$00.0000.00% ROIDNTHDianthus Therapeutics3/12/2025Reiterated Rating$23.06$84.00Buy$00.0000.00% ROIZBIOZenas BioPharma3/12/2025Reiterated Rating$8.43$45.00Buy$00.0000.00% ROIARGXargenex3/10/2025Boost Price Target$575.37$1,100.00Buy$000.0000.00% ROIIMVTImmunovant3/10/2025Reiterated Rating$20.28Buy$00.0000.00% ROINMRANeumora Therapeutics3/7/2025Downgrade$1.52Neutral$0.0000.00% ROISIONSionna Therapeutics3/4/2025Initiated Coverage$14.41$45.00Buy$00.0000.00% ROINBIXNeurocrine Biosciences2/10/2025Lower Price Target$122.62$163.00Buy$000.0000.00% ROIIMVTImmunovant2/10/2025Lower Price Target$20.41$44.00Buy$00.0000.00% ROIACADACADIA Pharmaceuticals1/3/2025Downgrade$18.66$20.00Neutral$00.0000.00% ROISRZNSurrozen1/3/2025Upgrade$14.25$45.00Buy$00.0000.00% ROIQTTBQ32 Bio12/11/2024Downgrade$7.90Neutral$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenWeiss RatingsUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.